Notice of Change to Key Dates for PAR-22-231 “NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)”
Notice Number:
NOT-NR-23-005

Key Dates

Release Date:

December 2, 2022

Related Announcements

PAR-22-231 - NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)

Issued by

National Institute of Nursing Research (NINR)

Purpose

The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-22-231 “NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional).” The August Advisory Council Review cycle is being changed to October. Changes to the Funding Opportunity Announcement (FOA) are shown below.


Currently Reads:

Part 1. Overview Information

Key Dates:

Advisory Council Review
May 2023
August 2023
January 2024
May 2024
August 2024
January 2025
May 2025
August 2025


 

Modified to Read (changes shown in bold italics):

Part 1. Overview Information

Key Dates:

Advisory Council Review
May 2023
October 2023
January 2024
May 2024
October 2024
January 2025
May 2025
October 2025


 

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

David L. Tilley, MPH, MS, CPH
National Institute of Nursing Research (NINR)
Telephone: 301-827-6014
Email: david.tilley@nih.gov